Palonidipine
Alternative Names: TC 81Latest Information Update: 22 May 1995
At a glance
- Originator Teijin Pharma
- Class Antihypertensives
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Hypertension
Most Recent Events
- 22 May 1995 Discontinued-preregistration for Angina pectoris in Japan (PO)
- 29 Mar 1995 Discontinued-preregistration for Hypertension in Japan (PO)